JAMA Network
About The Study: In participants with moderate to severe generalized anxiety disorder, a single dose of MM120 (lysergide D-tartrate) produced a dose-dependent reduction in anxiety. Lysergide, or lysergic acid diethylamide (LSD), is a semisynthetic psychedelic drug. An oral pharmaceutical formulation of LSD is MM120. These results support the dose-dependent efficacy of MM120 and inform the dose selection for phase 3 pivotal trials.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
